MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.76 -0.11 (-6.29%) 0.03 (1.81%) 0.01 (0.57%) -0.11 (-6.29%) --- --- -0.11 (-6.29%) -0.11 (-6.29%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-18.3256
Diluted P/E:
-18.3256
RSI(14) 1m:
52.82
VWAP:
1.63
RVol:
0.0959

Events

Period Kind Movement Occurred At
1m Price increase 1m 1.97 +0.03 (+1.55%) Oct 15 16:14
1m Price increase 1m 1.97 +0.03 (+1.55%) Oct 15 16:14
1m Price increase 1m 1.97 +0.03 (+1.55%) Oct 15 16:14
1m Price increase 1m 1.97 +0.03 (+1.55%) Oct 15 16:14
1m Price increase 1m 1.97 +0.03 (+1.55%) Oct 15 16:14

Related News